MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2018 International Congress

    Combination Therapy of Ellagic Acid and Mucuna Pruriens Seeds Extract Improves Rotenone Induced Behavioural, Oxidative and Mitochondrial Deficits in Mice Model of Parkinson’s Disease

    D. Khatri (Pune, India)

    Objective: The present study was designed in order to explore the possible synergistic effect of two highly naturally occurring bio-active compounds viz. Ellagic acid (EA)…
  • 2018 International Congress

    Erotophonophilia and severe impulse control disorder in a patient with Parkinson’s disease

    C. vander Linden, H. Colle, D. Colle, J. Jankovic (Ghent, Belgium)

    Objective: N/A Background: Paraphilia a form of hyper sexuality is a rare complication of dopaminergic drugs used in the treatment of Parkinson's disease (PD). We…
  • 2018 International Congress

    Oral treatment with sphingosine-1-phosphate receptors modulator prevents Parkinson symptoms concomitantly to reduced brain inflammation in MPTP mouse models

    M. Cyr, E. Pépin, G. Massicotte (Trois-Rivieres, QC, Canada)

    Objective: Here we explore the efficacy of an oral treatment with Fingolimod (FTY720), a selective sphingosine-1-phosphate receptors modulator, to prevent MPTP induced nigrostriatal loss and…
  • 2018 International Congress

    Executive dysfunctions and behavioral changes in early drug-naïve patients with Parkinson’s disease

    S. Li, R. Ou, X. Yuan, H. Liu, Y. Bing, Q. Wei, W. Song, B. Cao, Y. Chen, H. Shang (Chengdu, China)

    Objective: This study aims to explore the prevalence and onset age-related difference of executive dysfunctions and behavioral changes in drug-naïve patients with early stage of…
  • 2018 International Congress

    Impulse control disorders could be accompanied by hypomanic state under intestinal levodopa infusion

    K. Kashihara, M. Kitayama (Okayama, Japan)

    Objective: To determine characteristics of parkinsonian patients under levodopa/carbidopa intestinal gel (LCIG) infusion who present impulse control disorders (ICDs). Background: ICDs may be induced by…
  • 2018 International Congress

    Rasagiline as Adjunctive Therapy Induced Impulse Control Disorders in Parkinson’s Disease

    M. Şenol, M. Kendirli (Istanbul, Turkey)

    Objective: In recent years there are an increasing number of impulse control disorders (ICDs), such as pathologic gambling, hypersexuality, compulsive shopping, compulsive eating, punding and…
  • 2018 International Congress

    Movement disorder masquerading as seizure disorder

    K. Ganesh (Madurai, India)

    Objective: The main objective of presenting this case report is to emphasise the importance of accurate clinical diagnosis of movement disorder in children which many…
  • 2018 International Congress

    VIT-D and Tics Movement Disorder

    N. Gemawat (Mumbai, India)

    Objective: Tics is common childhood movement disorder, with classified variants , typically begin at around 4-5 years of age but often present later at about…
  • 2018 International Congress

    Acute concomitant presentation of chorea and subacute combined degeneration secondary to vitamin B12 deficiency

    E. Natera, F. Acebrón, A. Sánchez, V. Ros, A. Gómez, F. Ruiz, B. Zarza, C. Estévez, A. Alonso, JC. Martínez-Castrillo, I. Corral (Madrid, Spain)

    Objective: To describe an exceptional presentation of vitamin B12 deficiency. Background: Vitamin B12 deficiency typically presents with subacute combined degeneration (SCD). Extrapyramidal symptoms are rare,…
  • 2018 International Congress

    Neuroprotective role of cinnamaldehyde against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

    P. Kashyap, S. Gupta (Bihar, India)

    Objective: The present study examined the potential therapeutic effects of CA against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD and explored…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley